Skip to main content
Clinical Trials/ACTRN12607000631404
ACTRN12607000631404
Terminated
Phase 4

A double-blind randomised controlled trial of oxytocin bolus plus placebo infusion versus oxytocin bolus plus oxytocin infusion for the prevention of uterine atony and post partum haemorrhage at elective caesarean section.

Monash University0 sites948 target enrollmentDecember 12, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Postpartum haemorrhage
Sponsor
Monash University
Enrollment
948
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pregnancy: Singleton only Fetus: Alive only Gestation: 37 weeks \- 41 weeks Surgery: Elective lower segment caesarean section Anaesthesia: Regional anaesthesia (spinal, epidural, combined spinal epidural (CSE)) Past medical history: No significant maternal medical or obstetric disorders Parity: \<3 (equal to or less than 3\): Pre\-op Haemoglobin: Hb \> (equal to or more than) 100g/dl Language: Fluency in English Age: \>18 years of age (equal to or more than)

Exclusion Criteria

  • Active labour (presence of regular uterine activity accompanied by cervical dilation)
  • Emergency caesarean section
  • General anaesthesia
  • (Less than) \<37 completed weeks of pregnancy
  • Fetal demise
  • Multiple pregnancy
  • Polyhydramnios
  • Macrosomic fetus (Estimated fetal weight EFW \>4\.5 kg)
  • Past history of post partum haemorrhage 'PPH' requiring additional measures
  • Antepartum haemorrhage (requiring hospitalisation)

Outcomes

Primary Outcomes

Not specified

Similar Trials